Sodium-glucose co-transporter 2 inhibitors in heart failure: an updated evidence-based practical guidance for clinicians.

Monzo, Luca; Ferrari, Ilaria; Cicogna, Francesco; Tota, Claudia; Cice, Gennaro; Girerd, Nicolas; Calò, Leonardo

Monzo, Luca; Ferrari, Ilaria; Cicogna, Francesco; Tota, Claudia; Cice, Gennaro; Girerd, Nicolas; Calò, Leonardo.

Afiliação

Monzo L; Centre d'Investigation Clinique 1433 module Plurithématique, CHRU Nancy - Hôpitaux de Brabois, Institut Lorrain du CÅur et des Vaisseaux Louis Mathieu, Université de Lorraine INSERM, 4 rue du Morvan, 54500 Vandoeuvre les Nancy, France.
Ferrari I; Department of Cardiology, Policlinico Casilino, Rome 00169, Italy.
Cicogna F; Department of Cardiology, Policlinico Casilino, Rome 00169, Italy.
Tota C; Department of Cardiology, Policlinico Casilino, Rome 00169, Italy.
Cice G; Department of Cardiology, Policlinico Casilino, Rome 00169, Italy.
Girerd N; Department of Cardiology, Policlinico Casilino, Rome 00169, Italy.
Calò L; Centre d'Investigation Clinique 1433 module Plurithématique, CHRU Nancy - Hôpitaux de Brabois, Institut Lorrain du CÅur et des Vaisseaux Louis Mathieu, Université de Lorraine INSERM, 4 rue du Morvan, 54500 Vandoeuvre les Nancy, France.

Eur Heart J Suppl ; 25(Suppl C): C309-C315, 2023 May.

Article em En | MEDLINE | ID: mdl-37125324

Palavras-chave

Cardiovascular outcome trials; Clinical practical guide; Heart failure; SGLT2 inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Eur Heart J Suppl Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google